Clinical trial · Interventional
Improving Health Literacy in African-American Prostate Cancer Patients
NCT03322891CI-TRIAL-00102001recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators propose an observational interview study to explore how patients understand treatment conversations with their physicians within the framework of health literacy. The study team will test whether patients' understanding of treatment options and side effects can be improved when patients receive a low literacy educational supplement after meeting with their urologist. Investigators will interview a group of newly diagnosed, early stage, African American prostate cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Supplement | Other | — | UNRESOLVED |
| Standard Practice Education | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Educational Supplement
- description
- Participants diagnosed with prostate cancer will receive education for treatment options and treatment side effects.
- interventionNames
- Other: Educational Supplement
- Other: Standard Practice Education
Primary outcomes (3)
- measure
- Change in Decisional Conflict Scale Score
- timeFrame
- Baseline, Post-Intervention (Up to 6 Weeks)
- description
- The decisional conflict scale measures personal perceptions of : a) uncertainty in choosing options; b) modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making; and c) effective decision making such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).
- measure
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 25 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who have undergone pathology review of their prostate biopsy at Emory University, Grady Memorial Hospital, Saint Joseph's Hospital, and Atlanta VA Medical Center with AJCC clinical stage T1-T2 prostate cancer by physical exam Exclusion Criteria: * RN or MD degree * History of head injury or dementia * History of cognitive impairment * Unable to undergo the informed consent process and the study interview in English per the judgment of the primary urologist or urological provider
References
Publications (0)
Data not yet available
No reference posted for this study.